| Browse All

PROCEPT BioRobotics Corporation (PRCT)

Healthcare | Medical Devices | San Jose, United States | NasdaqGM
25.14 USD +0.62 (2.529%) ⇧ (April 17, 2026, 4 p.m. EDT)
After hours: 25.10 -0.04 (-0.040%) ⇩ (April 17, 2026, 7:14 p.m. EDT)

Short-term: ☆☆☆☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 18, 2026, 1:16 p.m. EDT

PRCT faces strong short-term bearish pressure: options flow favors puts, the forecasting model predicts a 9.4% drop, and recent price action shows weakness, signaling a high-conviction short-term sell or put-buy opportunity.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.087028
AutoTheta0.152796
AutoETS0.156588
MSTL0.160047

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 56%
H-stat 3.69
Ljung-Box p 0.012
Jarque-Bera p 0.423
Excess Kurtosis 0.06
Attribute Value
Sector Healthcare
Debt to Equity Ratio 21.451
Revenue per Share 5.546
Market Cap 1,417,649,536
Forward P/E -28.47
Beta 0.93
Profit Margins -31.02%
Website https://www.procept-biorobotics.com

As of April 18, 2026, 1:16 p.m. EDT: Speculators are heavily positioning for a short-term decline, with increased put activity and higher IV on OTM puts (e.g., 22.5 strike). ATM puts show elevated OI, while calls have limited activity. This suggests a bearish bias, with traders anticipating downside risk ahead of the earnings report.


Info Dump

Attribute Value
52 Week Change -0.52947783
Address1 150 Baytech Drive
All Time High 103.81
All Time Low 15.38
Ask 31.84
Ask Size 2
Audit Risk 6
Average Analyst Rating 2.0 - Buy
Average Daily Volume10 Day 1,300,200
Average Daily Volume3 Month 1,635,777
Average Volume 1,635,777
Average Volume10Days 1,300,200
Beta 0.931
Bid 18.04
Bid Size 2
Board Risk 5
Book Value 6.496
City San Jose
Compensation As Of Epoch Date 1,735,603,200
Compensation Risk 6
Country United States
Crypto Tradeable 0
Currency USD
Current Price 25.14
Current Ratio 6.845
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 25.4961
Day Low 24.69
Debt To Equity 21.451
Display Name PROCEPT BioRobotics
Earnings Call Timestamp End 1,777,494,600
Earnings Call Timestamp Start 1,777,494,600
Earnings Timestamp 1,777,492,800
Earnings Timestamp End 1,777,492,800
Earnings Timestamp Start 1,777,492,800
Ebitda -97,469,000
Ebitda Margins -0.3164
Enterprise To Ebitda -12.41
Enterprise To Revenue 3.927
Enterprise Value 1,209,629,568
Eps Current Year -1.543
Eps Forward -0.883
Eps Trailing Twelve Months -1.72
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 25.9862
Fifty Day Average Change -0.84620094
Fifty Day Average Change Percent -0.032563474
Fifty Two Week Change Percent -52.947784
Fifty Two Week High 66.85
Fifty Two Week High Change -41.71
Fifty Two Week High Change Percent -0.6239342
Fifty Two Week Low 19.35
Fifty Two Week Low Change 5.789999
Fifty Two Week Low Change Percent 0.29922473
Fifty Two Week Range 19.35 - 66.85
Financial Currency USD
First Trade Date Milliseconds 1,631,712,600,000
Float Shares 55,115,214
Forward Eps -0.883
Forward P E -28.47112
Free Cashflow -23,916,124
Full Exchange Name NasdaqGM
Full Time Employees 888
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,775,001,600
Gross Margins 0.63699
Gross Profits 196,226,000
Has Pre Post Market Data 1
Held Percent Insiders 0.03217
Held Percent Institutions 1.04548
Implied Shares Outstanding 56,390,196
Industry Medical Devices
Industry Disp Medical Devices
Industry Key medical-devices
Ipo Expected Date 2,021-09-15
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Long Name PROCEPT BioRobotics Corporation
Market us_market
Market Cap 1,417,649,536
Market State CLOSED
Max Age 86,400
Message Board Id finmb_248398889
Most Recent Quarter 1,767,139,200
Net Income To Common -95,572,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 1,417,649,527
Number Of Analyst Opinions 9
Open 24.69
Operating Cashflow -48,985,000
Operating Margins -0.40639
Overall Risk 6
Payout Ratio 0.0
Phone 650 232 7200
Post Market Change -0.03999901
Post Market Change Percent -0.15910505
Post Market Price 25.1
Post Market Time 1,776,467,685
Previous Close 24.52
Price Eps Current Year -16.292936
Price Hint 2
Price To Book 3.8700738
Price To Sales Trailing12 Months 4.601951
Profit Margins -0.31024
Quick Ratio 5.624
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 2.0
Region US
Regular Market Change 0.619999
Regular Market Change Percent 2.52854
Regular Market Day High 25.4961
Regular Market Day Low 24.69
Regular Market Day Range 24.69 - 25.4961
Regular Market Open 24.69
Regular Market Previous Close 24.52
Regular Market Price 25.14
Regular Market Time 1,776,456,000
Regular Market Volume 745,213
Return On Assets -0.12458
Return On Equity -0.24886
Revenue Growth 0.119
Revenue Per Share 5.546
Sand P52 Week Change 0.38150132
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 8
Shares Outstanding 56,390,196
Shares Percent Shares Out 0.103999995
Shares Short 5,867,315
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 6,387,391
Short Name PROCEPT BioRobotics Corporation
Short Percent Of Float 0.123
Short Ratio 3.25
Source Interval 15
State CA
Symbol PRCT
Target High Price 37.0
Target Low Price 20.0
Target Mean Price 30.11111
Target Median Price 30.0
Total Cash 286,503,008
Total Cash Per Share 5.081
Total Debt 78,483,000
Total Revenue 308,054,016
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.72
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 34.991123
Two Hundred Day Average Change -9.851124
Two Hundred Day Average Change Percent -0.28153208
Type Disp Equity
Volume 745,213
Website https://www.procept-biorobotics.com
Zip 95,134